Press Releases

MCRA and Clients Achieve Significant Milestone - Over 60 Breakthrough Device Designations Granted by FDA

MCRA and Clients Achieve Significant Milestone - Over 60 Breakthrough Device Designations Granted by FDA

MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA

MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S.</body></html>

MCRA Assists Net Health in Receiving Breakthrough Device Status

MCRA Assists Net Health in Receiving Breakthrough Device Status

MCRA Acquires Vorpal Technologies K.K. to Further Expand its Global Advisory Services in Japan

MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe - A New Tool to Measure Bone Tissue

MCRA Assists Multiple Clients with Successfully Obtaining CPT Codes and Hospital Payment Reassignments

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

MCRA Hires Melissa Paper, JD, MPA, CHC as Vice President of Healthcare Compliance

MCRA Expands Neurology Division into Neurointerventional Market

MCRA Expands Evidence Generation Service Line to Ensure Early Stakeholder Engagement for Optimal Product Adoption

MCRA Expands In-Vitro Diagnostic Device Expertise

MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices

Let Us Partner With You To Unlock Value

MCRA world class know-how and execution unlocks barriers, advancing our clients mission to better the availability of quality medical care to patients around the world.

© 2022

All Rights Reserved | Terms of Use | Privacy Policy